Peptostreptococcus Anaerobius enhances dextran sulfate sodium-induced colitis by promoting nf-κB-NLRP3-Dependent

Xu-Hang Shen1,2, Jing Guan1,2, De-Peng Lu1,2

  • 1Department of Gastroenterology, First Affiliated Hospital of Anhui Medical University, Hefei, China.

Virulence
|November 29, 2024
PubMed

Insights

Peptostreptococcus anaerobius exacerbates ulcerative colitis by triggering NLRP3 inflammasome activation and pyroptosis in macrophages. This bacterium disrupts gut barrier function and promotes inflammation via the TLR2/4-NF-κB-NLRP3 pathway.

Area of Science:

  • Microbiology
  • Immunology
  • Gastroenterology

Background:

  • Gut microbiota dysbiosis is implicated in ulcerative colitis (UC) pathogenesis.
  • Increased abundance of Peptostreptococcus species is observed in UC patients.
  • The precise role of Peptostreptococcus in intestinal inflammation remains unclear.

Purpose of the Study:

  • To investigate the role of Peptostreptococcus anaerobius in dextran sulfate sodium (DSS)-induced colitis.
  • To elucidate the molecular mechanisms underlying P. anaerobius-induced intestinal inflammation.
  • To identify potential therapeutic targets for UC.

Main Methods:

  • A DSS-induced colitis mouse model was utilized.
  • Bacterial gavage with different strains, including P. anaerobius, was performed.
  • Clinical, histological, immunological, and molecular analyses were conducted.
  • In vitro assays with bone marrow-derived macrophages (BMDMs) were employed.
  • Inhibitors of Toll-like receptor (TLR) and NOD-like receptor family pyrin domain-containing 3 (NLRP3) pathways were used.

Main Results:

  • P. anaerobius administration aggravated intestinal inflammation and barrier dysfunction in DSS-induced colitis.
  • P. anaerobius induced gut microbiota dysbiosis during colitis.
  • P. anaerobius activated the NLRP3 inflammasome, leading to pyroptosis and IL-1β secretion in macrophages.
  • TLR2 and TLR4 were identified as crucial mediators, activating the NF-κB-NLRP3 pathway.

Conclusions:

  • P. anaerobius promotes macrophage pyroptosis and IL-1β secretion via the TLR2/4-NF-κB-NLRP3 signaling axis, exacerbating colitis.
  • P. anaerobius may serve as a potential risk factor for UC development.
  • Targeting the TLR-NLRP3 inflammasome pathway could be a therapeutic strategy for UC.

Related Concept Videos

Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds to M3...
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...